Mark Shirley
Papers
1
Total Citations
113
H-Index
1
About
Mark Shirley is a leading health technology assessment researcher whose work has profoundly shaped the economic evaluation of surgical innovations in urological oncology. His primary research areas center on the comparative effectiveness and cost-utility of robotic-assisted surgery versus conventional laparoscopic and open approaches, particularly for prostate cancer treatment. Shirley’s landmark health technology assessment, which has garnered over 110 citations, provided the UK National Health Service with a rigorous, real-world analysis of the cost-effectiveness of robot-assisted laparoscopic prostatectomy. By integrating clinical outcomes with detailed economic modeling, his work demonstrated that while robotic surgery offers certain perioperative advantages, its significantly higher costs often fail to deliver proportional health gains, directly influencing national reimbursement and adoption policies. Beyond this flagship study, Shirley is recognized for advancing methodological frameworks in surgical health economics, ensuring that technology diffusion is guided by evidence of value rather than novelty. His contributions have made him a trusted voice in policy debates, helping to balance innovation with fiscal responsibility in publicly funded healthcare systems.
Research Focus
Key Achievements
Top Papers
- 1